Chemical Structure (Orladeyo 01)
Orladeyo Pellet
Product Images NDC 72769-113
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Orladeyo (NDC 72769-113). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Biocryst Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Orladeyo 02)
Figure 2 (Orladeyo 03)
Principal Display Panel (150 mg Capsule Blister Card Shellpack Carton)
Principal Display Panel (110 mg Capsule Blister Card Shellpack Carton)
This is a description of two medications named Orladeyo and Berotralstat. Orladeyo is available in capsule form and contains 10mg of the active ingredient Ertaltaapes. Berotralstat capsules contain 110mg of the active ingredient but its usage purposes are not mentioned in the text. The package includes 28 capsules with four shell packs, each containing a 7-capsule blister card. However, it is not clear what the medication is used for.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
